Mettler-Toledo International, Inc. (NYSE:MTD) Shares Bought by Boston Trust Walden Corp

Boston Trust Walden Corp boosted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 7.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 34,610 shares of the medical instruments supplier's stock after buying an additional 2,296 shares during the quarter. Boston Trust Walden Corp owned 0.17% of Mettler-Toledo International worth $40,871,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Farther Finance Advisors LLC lifted its position in shares of Mettler-Toledo International by 39.1% during the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after purchasing an additional 25 shares during the last quarter. Allworth Financial LP lifted its position in shares of Mettler-Toledo International by 367.4% during the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock worth $285,000 after purchasing an additional 169 shares during the last quarter. QRG Capital Management Inc. lifted its position in shares of Mettler-Toledo International by 29.4% during the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock worth $577,000 after purchasing an additional 111 shares during the last quarter. Royal Bank of Canada lifted its position in shares of Mettler-Toledo International by 7.3% during the fourth quarter. Royal Bank of Canada now owns 45,756 shares of the medical instruments supplier's stock worth $55,990,000 after purchasing an additional 3,105 shares during the last quarter. Finally, Impax Asset Management Group plc raised its holdings in shares of Mettler-Toledo International by 5.8% in the fourth quarter. Impax Asset Management Group plc now owns 198,852 shares of the medical instruments supplier's stock valued at $243,331,000 after acquiring an additional 10,830 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts recently weighed in on MTD shares. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a report on Monday, May 5th. Robert W. Baird reduced their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a report on Tuesday, April 22nd. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their target price for the stock from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a report on Monday, April 7th. Finally, Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and reduced their target price for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $1,302.11.

Insider Activity

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the transaction, the director now owns 120 shares of the company's stock, valued at $139,191.60. The trade was a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.77% of the company's stock.

Mettler-Toledo International Trading Up 0.9%

Mettler-Toledo International stock traded up $10.60 during midday trading on Monday, reaching $1,164.53. 138,396 shares of the stock traded hands, compared to its average volume of 152,105. The company has a 50-day simple moving average of $1,120.21 and a two-hundred day simple moving average of $1,199.56. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,546.93. The firm has a market cap of $24.20 billion, a PE ratio of 29.04, a price-to-earnings-growth ratio of 3.42 and a beta of 1.38.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.90 by $0.29. The business had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The business's quarterly revenue was down 4.6% compared to the same quarter last year. During the same quarter last year, the business posted $8.89 EPS. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.